Ziccum AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)

  • by

    • Ziccum today announces a change of Certified Adviser from Erik Penser Bank AB to Carnegie Investment Bank AB (publ).

    Ziccum has entered into an agreement with Carnegie Investment Bank AB (publ) regarding the position as Certified Adviser. Carnegie Investment Bank AB (publ) will take over as Certified Adviser on November 30, 2023. Until then, Erik Penser Bank AB will continue to act as Certified Adviser to the company..

    For more information about Ziccum, please contact:

    Ann Gidner,
    CEO Ziccum
    Mail: gidner@ziccum.com
    Mobile: +46 722140141

    Fredrik Sjövall,
    Chairman of the Board, Ziccum AB
    Mail: sjovall@ziccum.com
    Mobile: +46 706 45 08 75
     
    Ziccum’s Certified Adviser is
    Carnegie Investment Bank AB (publ).
    Follow us on https://eucaps.com/ziccum

    About Ziccum

    Ziccum is developing LaminarPaceTM, a unique drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. The technology is offered by licensing to vaccine and biologics developers and manufacturers in the global pharmaceutical industry. By reducing drying stress to the active ingredient, LaminarPaceTM uniquely enables particle-engineered, thermostable dry powder biopharmaceuticals which can be easily handled and transported and are highly suitable for novel administration routes. The technology has been successfully applied to mRNA, peptides, proteins, antibodies, lipids and enzymes as well as excipients and adjuvants, and is well suited for industrial application. Ziccum is listed on the Nasdaq First North Growth Market.

    Attachments

    Ziccum AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)

    Ziccum AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)